ATC code None PubChem CID 10331863 Formula C15H13FN2 Molar mass 240.276 g/mol | CAS Number 757950-09-7 ChemSpider 8507323 3D model (Jmol) Interactive image | |
 | ||
Raseglurant (INN) (code name ADX-10059) is a negative allosteric modulator of the mGlu5 receptor and derivative of MPEP which was under development by Addex Therapeutics for the treatment of migraine, gastroesophageal reflux disease, and dental anxiety. It reached phase II clinical trials for all of the aforementioned indications before being discontinued due to the observation of possible predictive signs of hepatotoxicity in patients with long-term use.
References
Raseglurant Wikipedia(Text) CC BY-SA